Jean‐Marc Schwarz

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir”.

Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir

AIDS Research and Therapy(2023)10.1186/s12981-023-00510-6

N/A

0DataRank · unranked

24 citations

Barbara Castelnuovo, Nele Brusselaers, Robert C. Bollinger, Joshua Rhein, Mutebi Edrisa +11 more

Prevalence of Cardiometabolic Disease Risk Factors in People with HIV Initiating Anti-retroviral Therapy at a High-Volume HIV Clinic in Kampala, Uganda

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad241

N/A

0DataRank · unranked

19 citations

Frank Mulindwa, Barbara Castelnuovo, Nele Brusselaers, Jean‐Marc Schwarz, Mutebi Edrisa +4 more

Prevalence of Cardiometabolic Disease Risk Factors in People living with HIV Initiating Anti-retroviral Therapy at a High-Volume HIV Clinic in Kampala, Uganda

medRxiv(2023)10.1101/2023.03.18.23287437

N/A

0DataRank · unranked

0 citations

Frank Mulindwa, Barbara Castelnuovo, Nele Brusselaers, Jean‐Marc Schwarz, Mutebi Edrisa +4 more

Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults

Research Square(2023)10.21203/rs.3.rs-3175598/v1

N/A

0DataRank · unranked

0 citations

Barbara Castelnuovo, Nele Brusselaers, Martin Nabwana, Robert C. Bollinger, Eva Laker +3 more

Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks

Research Square(2023)10.21203/rs.3.rs-3154716/v1

N/A

0DataRank · unranked

0 citations

Jean‐Marc Schwarz, Nele Brusselaers, Martin Nabwana, Robert C. Bollinger, Allan Buzibye +6 more

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report

Research Square(2023)10.21203/rs.3.rs-3218404/v1

N/A

0DataRank · unranked

0 citations

Barbara Castelnuovo, Nele Brusselaers, Robert C. Bollinger, George A. Yendewa, Willington Amutuhaire +3 more

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report

BMC Infectious Diseases(2023)10.1186/s12879-023-08712-z

N/A

0DataRank · unranked

0 citations

Barbara Castelnuovo, Nele Brusselaers, Robert C. Bollinger, George A. Yendewa, Willington Amutuhaire +3 more

Effects of Consuming Beverages Sweetened with Fructose, Glucose, High-Fructose Corn Syrup, Sucrose, or Aspartame on OGTT-Derived Indices of Insulin Sensitivity in Young Adults

Nutrients(2024)10.3390/nu16010151

N/A

0DataRank · unranked

14 citations

Valentina Medici, Vivien Lee, Marinelle V. Nuñez, Desiree M. Sigala, Andrew A. Bremer +8 more

Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks

BMC Infectious Diseases(2024)10.1186/s12879-024-09655-9

N/A

0DataRank · unranked

1 citations

Jean‐Marc Schwarz, Nele Brusselaers, Martin Nabwana, Robert C. Bollinger, Allan Buzibye +6 more